{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T19:33:54Z","timestamp":1773257634327,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Andrews University Faculty Grant","award":["N\/A\/"],"award-info":[{"award-number":["N\/A\/"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s43440-025-00815-5","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T11:32:54Z","timestamp":1767612774000},"page":"607-614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Docosahexaenoic acid modulates myo-inositol and myo-inositol biosynthetic genes expression: implications for bipolar disorder"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9621-5860","authenticated-orcid":false,"given":"Marlene","family":"Murray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4398-7946","authenticated-orcid":false,"given":"Haley","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taejun","family":"Ok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3001-5764","authenticated-orcid":false,"given":"Kimberly","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7109-0346","authenticated-orcid":false,"given":"Joanne Jee Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3814-4026","authenticated-orcid":false,"given":"Bomi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8364-9668","authenticated-orcid":false,"given":"Hyukje","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1021-9115","authenticated-orcid":false,"given":"Talisa","family":"Tait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2385-125X","authenticated-orcid":false,"given":"Daniel Colon","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4306-9060","authenticated-orcid":false,"given":"Yudy","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"2","key":"815_CR1","first-page":"121","volume":"16","author":"K Merinkangas","year":"2009","unstructured":"Merinkangas K, Pato M. Recent developments in the epidemiology of bipolar disorder in adults and children: Magnitude, Correlates, and future directions. Clin Psychology: Sci Pract. 2009;16(2):121\u201333.","journal-title":"Clin Psychology: Sci Pract"},{"key":"815_CR2","doi-asserted-by":"publisher","first-page":"101135","DOI":"10.1016\/j.lanepe.2024.101135","volume":"48","author":"V Oliva","year":"2024","unstructured":"Oliva V, Fico G, De Prisco M, Gonda X, Rosa AR, Vieta E. Bipolar disorders: an update on critical aspects. Lancet Reg Health Eur. 2024;48:101135. https:\/\/doi.org\/10.1016\/j.lanepe.2024.101135.","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"815_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.5152\/alphapsychiatry.2024.241474","volume":"25","author":"A Aguglia","year":"2024","unstructured":"Aguglia A, Giacomini G, De Michiel CF, Garbarino N, Lechiara A, Magni C, Meinero M, Verrina E, Costanza A, Amerio A, Amore M, Serafini G. Characterization of bipolar disorder I and II: clinical Features, Comorbidities, and Pharmacological pattern. Alpha Psychiatr. 2024;25(4):472\u20139. https:\/\/doi.org\/10.5152\/alphapsychiatry.2024.241474.","journal-title":"Alpha Psychiatr"},{"issue":"3","key":"815_CR4","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1192\/bjo.2024.51","volume":"10","author":"F Bartoli","year":"2024","unstructured":"Bartoli F, Bassetti C, Gazzola M, Gianfelice L, Cavaleri D, Crocamo C, Carr\u00e0 G. Prevalence and correlates of manic\/hypomanic and depressive predominant Polarity in bipolar disorder: systematic review and meta-analysis. BJPsych Open. 2024;10(3):e100. https:\/\/doi.org\/10.1192\/bjo.2024.51.","journal-title":"BJPsych Open"},{"issue":"14","key":"815_CR5","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1001\/jama.2023.18588","volume":"330","author":"AA Nierenberg","year":"2023","unstructured":"Nierenberg AA, Agustini B, K\u00f6hler-Forsberg O, Cusin C, Katz D, Sylvia LG, Peters A, Berk M. Diagnosis and treatment of bipolar disorder: A review. JAMA. 2023;330(14):1370\u201380. https:\/\/doi.org\/10.1001\/jama.2023.18588.","journal-title":"JAMA"},{"issue":"2","key":"815_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/14737175.2023.2181076","volume":"23","author":"JK Rybakowski","year":"2023","unstructured":"Rybakowski JK, Borensztajn-Rochowiak E. Updated perspectives on how and when lithium should be used in the treatment of mood disorders. Expert Rev Neurother. 2023;23(2):157\u201367. https:\/\/doi.org\/10.1080\/14737175.2023.2181076.","journal-title":"Expert Rev Neurother"},{"key":"815_CR7","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1046\/j.1471-4159.1996.66062402.x","volume":"66","author":"RS Jope","year":"1996","unstructured":"Jope RS, Song L, Li PP, Young LT, Kish SJ, Pacheco MA. The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J Neurochem. 1996;66:2402\u20139.","journal-title":"J Neurochem"},{"issue":"8","key":"815_CR8","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1176\/ajp.150.8.1252","volume":"150","author":"AS Brown","year":"1993","unstructured":"Brown AS, Mallinger AG, Renbaum LC. Elevated platelet membrane phosphatidylinositol-4,5-bisphosphate in bipolar mania. Am J Psychiatry. 1993;150(8):1252\u20134.","journal-title":"Am J Psychiatry"},{"key":"815_CR9","doi-asserted-by":"publisher","unstructured":"Bergamelli E, Del Fabro L, Delvecchio G, D\u2019Agostino A, Brambilla P. The impact of lithium on brain function in bipolar disorder: an updated review of functional magnetic resonance imaging studies. CNS Drugs. 2021; Dec;35(12):1275\u20131287. https:\/\/doi.org\/10.1007\/s40263-021-00869-y. Epub 2021 Nov 12. Erratum in: CNS Drugs. 2022;36(11):1241. https:\/\/doi.org\/10.1007\/s40263-022-00962-w. PMID: 34773217; PMCID: PMC9537229.","DOI":"10.1007\/s40263-022-00962-w"},{"issue":"1","key":"815_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/ph15010105","volume":"15","author":"M Carli","year":"2022","unstructured":"Carli M, Risaliti E, Francomano M, Kolachalam S, Longoni B, Bocci G, Maggio R, Scarselli M. A 5-Year study of lithium and valproic acid drug monitoring in patients with bipolar disorders in an Italian clinical center. Pharmaceuticals (Basel). 2022;15(1):105. https:\/\/doi.org\/10.3390\/ph15010105.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"815_CR11","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1176\/ajp.156.12.1902","volume":"156","author":"GJ Moore","year":"1999","unstructured":"Moore GJ, Bebchuk JM, Parrish JK, Faulk MW, Arfken CL, Strahl-Bevacqua J, Manji HK. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry. 1999;156(12):1902\u20138. https:\/\/doi.org\/10.1176\/ajp.156.12.1902.","journal-title":"Am J Psychiatry"},{"issue":"11","key":"815_CR12","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.biopsych.2004.08.027","volume":"56","author":"G Shaltiel","year":"2004","unstructured":"Shaltiel G, Shamir A, Shapiro J, Ding D, Dalton E, Bialer M, et al. Valproate decreases inositol biosynthesis. Biol Psychiatry. 2004;56(11):868\u201374.","journal-title":"Biol Psychiatry"},{"issue":"Suppl 2","key":"815_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1399-5618.2009.00714.x","volume":"11","author":"R Machado-Vieira","year":"2009","unstructured":"Machado-Vieira R, Manji HK, Zarate CA. Jr. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord. 2009;11(Suppl 2):92\u2013109. https:\/\/doi.org\/10.1111\/j.1399-5618.2009.00714.x.","journal-title":"Bipolar Disord"},{"key":"815_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jpsychires.2021.09.018","volume":"143","author":"F Bartoli","year":"2021","unstructured":"Bartoli F, Cavaleri D, Bachi B, Moretti F, Riboldi I, Crocamo C, Carr\u00e0 G. Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials. J Psychiatr Res. 2021;143:230\u20138. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.09.018.","journal-title":"J Psychiatr Res"},{"key":"815_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1192\/bjp.188.1.46","volume":"188","author":"S Frangou","year":"2006","unstructured":"Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomized double-blind placebo-controlled study. Br J Psychiatry. 2006;188:46\u201350.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"815_CR16","first-page":"585","volume":"46","author":"K Krawczyk","year":"2012","unstructured":"Krawczyk K, Rybakowski J. Augmentation of antidepressants with unsaturated fatty acids omega-3 in drug-resistant depression. Psychiatr Pol. 2012;46(4):585\u201398.","journal-title":"Psychiatr Pol"},{"issue":"2","key":"815_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/md23020084","volume":"23","author":"E Psara","year":"2025","unstructured":"Psara E, Papadopoulou SK, Mentzelou M, Voulgaridou G, Vorvolakos T, Apostolou T, Giaginis C. Omega-3 fatty acids for the treatment of bipolar disorder symptoms: A narrative review of the current clinical evidence. Mar Drugs. 2025;23(2):84. https:\/\/doi.org\/10.3390\/md23020084.","journal-title":"Mar Drugs"},{"issue":"14","key":"815_CR18","doi-asserted-by":"publisher","first-page":"10888","DOI":"10.1074\/jbc.M008150200","volume":"276","author":"B Mirnikjoo","year":"2001","unstructured":"Mirnikjoo B, Brown SE, Kim HF, Marangell LB, Sweatt JD, Weeber EJ. Protein kinase Inhibition by omega-3 fatty acids. J Biol Chem. 2001;276(14):10888\u201396.","journal-title":"J Biol Chem"},{"issue":"2","key":"815_CR19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1172\/JCI116245","volume":"91","author":"RI Sperling","year":"1993","unstructured":"Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest. 1993;91(2):651\u201360.","journal-title":"J Clin Invest"},{"issue":"4:3","key":"815_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/15622970802485276","volume":"10","author":"D Ding","year":"2009","unstructured":"Ding D, Shi Y, Shaltiel G, Azab AN, Pullumbi E, Campbell A, et al. Yeast bioassay for identification of inositol-depleting compounds. World J Biol Psychiatry. 2009;10(4:3):893\u20139.","journal-title":"World J Biol Psychiatry"},{"issue":"3","key":"815_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jad.2009.07.001","volume":"122","author":"AN Azab","year":"2009","unstructured":"Azab AN, Ifergane G, Ben-Shachar D. The possible involvement of inositol biosynthesis in the mechanism of action of valproate: studies in yeast. J Affect Disord. 2009;122(3):216\u201325. https:\/\/doi.org\/10.1016\/j.jad.2009.07.001.","journal-title":"J Affect Disord"},{"issue":"8","key":"815_CR22","doi-asserted-by":"publisher","first-page":"e0182534","DOI":"10.1371\/journal.pone.0182534","volume":"12","author":"W Yu","year":"2017","unstructured":"Yu W, Daniel J, Cheng J, et al. MCK1 is a novel regulator of myo-inositol-3-phosphate synthase (MIPS) and is required for Inhibition of inositol synthesis by valproic acid in yeast. PLoS ONE. 2017;12(8):e0182534. https:\/\/doi.org\/10.1371\/journal.pone.0182534.","journal-title":"PLoS ONE"},{"issue":"1","key":"815_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/genetics\/80.1.23","volume":"80","author":"MR Culbertson","year":"1975","unstructured":"Culbertson MR, Henry SA. Inositol-requiring mutants of Saccharomyces cerevisiae. Genetics. 1975;80(1):23\u201340.","journal-title":"Genetics"},{"key":"815_CR24","doi-asserted-by":"publisher","first-page":"14844","DOI":"10.1038\/s41598-023-41936-2","volume":"13","author":"KC Case","year":"2023","unstructured":"Case KC, Beltman RJ, Pflum MK, Greenberg ML. Valproate regulates inositol synthesis by reducing expression of myo-inositol-3-phosphate synthase. Scic Rep. 2023;13:14844. https:\/\/doi.org\/10.1038\/s41598-023-41936-2.","journal-title":"Scic Rep"},{"issue":"1","key":"815_CR25","doi-asserted-by":"publisher","first-page":"24601","DOI":"10.1038\/s41598-025-07540-2","volume":"15","author":"KC Case","year":"2025","unstructured":"Case KC, Orkun L, Greenberg ML. Valproate independently activates Snf1, inhibits TORC1, and induces repression of INO1 transcription by increasing nuclear localization of Opi1. Sci Rep. 2025;15(1):24601. https:\/\/doi.org\/10.1038\/s41598-025-07540-2.","journal-title":"Sci Rep"},{"key":"815_CR26","doi-asserted-by":"crossref","unstructured":"Vaden DL, Ding D, Peterson B, Greenberg ML. 2001. Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis. J Biol. Chem. 2001;276(19):15466\u201315471.","DOI":"10.1074\/jbc.M004179200"},{"issue":"8","key":"815_CR27","doi-asserted-by":"publisher","first-page":"10994","DOI":"10.1096\/fj.201902517R","volume":"34","author":"A Loehfelm","year":"2020","unstructured":"Loehfelm A, Elder M, Boucsein A, Jones P, Williams J, Tups A. Docosahexaenoic acid prevents palmitate-induced insulin resistance: mechanisms involving mitochondrial function in primary cortical neurons. FASEB J. 2020;34(8):10994\u20131009. https:\/\/doi.org\/10.1096\/fj.201902517R.","journal-title":"FASEB J"},{"issue":"10","key":"815_CR28","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.3390\/ijms23105390","volume":"23","author":"A. B. Petermann","year":"2022","unstructured":"Petermann AB, Reyna-Jeldes M, Ortega L, Coddou C, Y\u00e9venes GE. Roles of the unsaturated fatty acid docosahexaenoic acid in the central nervous system: molecular and cellular insightts. Int. J Mol Sci. 2022;23(10), 5390. https:\/\/doi.org\/10.3390\/ijms23105390","journal-title":"Int. J Mol Sci"},{"issue":"1\u20132","key":"815_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0165-022X(00)00069-5","volume":"44","author":"N Ashizawa","year":"2000","unstructured":"Ashizawa N, Yoshida M, Aotsuka T. An enzymatic assay for myo-inositol in tissue samples. J Biochem Biophys Methods. 2000;44(1\u20132):89\u201394.","journal-title":"J Biochem Biophys Methods"},{"issue":"4","key":"815_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2013\u2206\u2206CT Method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"3","key":"815_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1046\/j.1365-2958.2000.01886.x","volume":"36","author":"M Murray","year":"2000","unstructured":"Murray M, Greenberg ML. Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate. Mol Micro. 2000;36(3):651\u201361.","journal-title":"Mol Micro"},{"issue":"11","key":"815_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-087999","volume":"14","author":"J Mari","year":"2024","unstructured":"Mari J, Dieckmann LHJ, Prates-Baldez D, Haddad M, Rodrigues da Silva N, Kapczinski F. The efficacy of valproate in acute mania, bipolar depression and maintenance therapy for bipolar disorder: an overview of systematic reviews with meta-analyses. BMJ Open. 2024;14(11):e087999. https:\/\/doi.org\/10.1136\/bmjopen-2024-087999","journal-title":"BMJ Open"},{"key":"815_CR33","doi-asserted-by":"publisher","unstructured":"Vasudev K, Sharma P. Is valproate depressogenic in patients remitting from acute mania? Case Series. Case Rep Psychiatry. 2015; 2015:456830. Epub 2015 Nov 17. PMID: 26664794; PMCID: PMC4664792. https:\/\/doi.org\/10.1155\/2015\/456830","DOI":"10.1155\/2015\/456830"},{"issue":"6","key":"815_CR34","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/s0022-3956(98)00033-8","volume":"32","author":"R Frey","year":"1998","unstructured":"Frey R, Metzler D, Fischer P, Heiden A, Scharfetter J, Moser E, Kasper S. Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 Tesla. J Psychiatr Res. 1998;32(6):411\u201320. https:\/\/doi.org\/10.1016\/s0022-3956(98)00033-8.","journal-title":"J Psychiatr Res"},{"issue":"4","key":"815_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0893-133X(00)00207-4","volume":"24","author":"P Davanzo","year":"2001","unstructured":"Davanzo P, Thomas MA, Yue K, Oshiro T, Belin T, Strober M, McCracken J. Decreased anterior cingulate myo-inositol\/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology. 2001;24(4):359\u201369. https:\/\/doi.org\/10.1016\/S0893-133X(00)00207-4.","journal-title":"Neuropsychopharmacology"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00815-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00815-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00815-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T02:35:08Z","timestamp":1773196508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00815-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00815-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7207940\/v1","asserted-by":"object"}]},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}